Antibiotic Abuse and Antimicrobial Resistance in Hospital Environment: A Retrospective Observational Comparative Study.
Patrizia NardulliGabriel Gustafsson HallAlessandro QuartaGiovanni FruscioMariarita LaforgiaVito M GarrisiRoberta RuggieroSalvatore ScaccoDanila de VitoPublished in: Medicina (Kaunas, Lithuania) (2022)
Background and Objectives : Antimicrobial resistance represents a serious problem, and it may be life-threatening in the case of severe hospital-acquired infections (HAI). Antibiotic abuse and multidrug resistance (MDR) have significantly increased this burden in the last decades. The aim of this study was to investigate the distribution and susceptibility rates of five selected bacterial species ( E. coli , K. pneumoniae , P. aeruginosa , S. aureus and E. faecium ) in two healthcare settings located in the Apulia region (Italy). Materials and Methods : Setting n.1 was a university hospital and setting n.2 was a research institute working on oncological patients. All the enrolled patients were diagnosed for bacterial HAI. The observation period was between August and September 2021. Clinical samples were obtained from several biological sources, in different hospital wards. Bacterial identification and susceptibility were tested by using the software VITEC 2 Single system. Results : In this study, a higher incidence of multi-drug-resistant K. pneumoniae was reported (42,2% in setting n.1 and 50% in setting n.2), with respect to the Italian 2019 statistics report (30.3%). All the isolates of E. faecium and S. aureus were susceptible to linezolid. All the bacterial isolates of P. aeruginosa and most of K. pneumoniae were susceptible to ceftazidime-avibactam. Amikacin and nitrofurantoin represented a good option for treating E. coli infections. Multidrug-resistant (MDR) P. aeruginosa , methicillin-resistant S. aureus (MRSA) and vancomycin-resistant E. faecium (VRE) had a lower incidence in the clinical setting, with respect to E. coli and K. pneumoniae. Conclusions : The data obtained in this study can support clinicians towards a rational and safe use of antibiotics for treating the infections caused by these resistant strains, to enhance the overall efficacy of the current antibiotic protocols used in the main healthcare environments.
Keyphrases
- multidrug resistant
- healthcare
- antimicrobial resistance
- drug resistant
- end stage renal disease
- escherichia coli
- gram negative
- methicillin resistant staphylococcus aureus
- ejection fraction
- chronic kidney disease
- newly diagnosed
- acinetobacter baumannii
- staphylococcus aureus
- risk factors
- peritoneal dialysis
- emergency department
- klebsiella pneumoniae
- prognostic factors
- machine learning
- acute care
- rectal cancer
- pseudomonas aeruginosa
- artificial intelligence
- social media
- genetic diversity